Overseeing research on therapeutic cloning: a private ethics board responds to its critics.

Ronald M. Green, Kier Olsen DeVries, Judith Bernstein, Kenneth Goodman, Robert Kaufmann, Ann A. Kiessling, Susan R. Levin, Susan L. Moss, Carol A. Tauer

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Advanced Cell Technology's Ethics Advisory Board has been called window dressing for a corporate marketing plan. But the scientists and managers have paid attention, and the lawyers have gone along.

Original languageEnglish
Pages (from-to)27-33
Number of pages7
JournalThe Hastings Center report
Volume32
Issue number3
StatePublished - May 1 2002
Externally publishedYes

Fingerprint

Therapeutic Human Experimentation
Lawyers
Marketing
Ethics
lawyer
Organism Cloning
critic
marketing
moral philosophy
manager
Technology
Cells
Therapeutics
Managers
Cloning

ASJC Scopus subject areas

  • Nursing(all)
  • Medicine (miscellaneous)
  • Social Sciences (miscellaneous)

Cite this

Green, R. M., DeVries, K. O., Bernstein, J., Goodman, K., Kaufmann, R., Kiessling, A. A., ... Tauer, C. A. (2002). Overseeing research on therapeutic cloning: a private ethics board responds to its critics. The Hastings Center report, 32(3), 27-33.

Overseeing research on therapeutic cloning : a private ethics board responds to its critics. / Green, Ronald M.; DeVries, Kier Olsen; Bernstein, Judith; Goodman, Kenneth; Kaufmann, Robert; Kiessling, Ann A.; Levin, Susan R.; Moss, Susan L.; Tauer, Carol A.

In: The Hastings Center report, Vol. 32, No. 3, 01.05.2002, p. 27-33.

Research output: Contribution to journalArticle

Green, RM, DeVries, KO, Bernstein, J, Goodman, K, Kaufmann, R, Kiessling, AA, Levin, SR, Moss, SL & Tauer, CA 2002, 'Overseeing research on therapeutic cloning: a private ethics board responds to its critics.', The Hastings Center report, vol. 32, no. 3, pp. 27-33.
Green RM, DeVries KO, Bernstein J, Goodman K, Kaufmann R, Kiessling AA et al. Overseeing research on therapeutic cloning: a private ethics board responds to its critics. The Hastings Center report. 2002 May 1;32(3):27-33.
Green, Ronald M. ; DeVries, Kier Olsen ; Bernstein, Judith ; Goodman, Kenneth ; Kaufmann, Robert ; Kiessling, Ann A. ; Levin, Susan R. ; Moss, Susan L. ; Tauer, Carol A. / Overseeing research on therapeutic cloning : a private ethics board responds to its critics. In: The Hastings Center report. 2002 ; Vol. 32, No. 3. pp. 27-33.
@article{ba9e40d66a3248edb107f08497d373d6,
title = "Overseeing research on therapeutic cloning: a private ethics board responds to its critics.",
abstract = "Advanced Cell Technology's Ethics Advisory Board has been called window dressing for a corporate marketing plan. But the scientists and managers have paid attention, and the lawyers have gone along.",
author = "Green, {Ronald M.} and DeVries, {Kier Olsen} and Judith Bernstein and Kenneth Goodman and Robert Kaufmann and Kiessling, {Ann A.} and Levin, {Susan R.} and Moss, {Susan L.} and Tauer, {Carol A.}",
year = "2002",
month = "5",
day = "1",
language = "English",
volume = "32",
pages = "27--33",
journal = "Hastings Center Report",
issn = "0093-0334",
publisher = "Hastings Center",
number = "3",

}

TY - JOUR

T1 - Overseeing research on therapeutic cloning

T2 - a private ethics board responds to its critics.

AU - Green, Ronald M.

AU - DeVries, Kier Olsen

AU - Bernstein, Judith

AU - Goodman, Kenneth

AU - Kaufmann, Robert

AU - Kiessling, Ann A.

AU - Levin, Susan R.

AU - Moss, Susan L.

AU - Tauer, Carol A.

PY - 2002/5/1

Y1 - 2002/5/1

N2 - Advanced Cell Technology's Ethics Advisory Board has been called window dressing for a corporate marketing plan. But the scientists and managers have paid attention, and the lawyers have gone along.

AB - Advanced Cell Technology's Ethics Advisory Board has been called window dressing for a corporate marketing plan. But the scientists and managers have paid attention, and the lawyers have gone along.

UR - http://www.scopus.com/inward/record.url?scp=0036580173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036580173&partnerID=8YFLogxK

M3 - Article

C2 - 12085512

AN - SCOPUS:0036580173

VL - 32

SP - 27

EP - 33

JO - Hastings Center Report

JF - Hastings Center Report

SN - 0093-0334

IS - 3

ER -